LongeVC managing partner Sergey Jakimov was featured in Investing News Network's biotech market forecast for 2026, discussing how AI is reshaping drug discovery and clinical care delivery.
Sergey highlighted two transformative trends: the emergence of "micro-pharma" - lean, 10-person teams leveraging AI for discovery programs that previously required Big Pharma resources, and the rise of the "doctor in your hand," an AI companion managing routine clinical tasks between visits.
Read the full article here.
Sergey highlighted two transformative trends: the emergence of "micro-pharma" - lean, 10-person teams leveraging AI for discovery programs that previously required Big Pharma resources, and the rise of the "doctor in your hand," an AI companion managing routine clinical tasks between visits.
Read the full article here.